Veranova has invested over 50 years building an extensive range of controlled substances, including opioids, stimulants, and cannabinoids. Backed by unparalleled experience, global GMP capabilities, and regulatory excellence, our team has the expertise to manage the sustainable, secure supply and manufacturing of these APIs with confidence.
Explore our portfolio of controlled substances
Many of the most promising therapeutics in development utilize controlled substances, spanning oncology, pain management, addiction treatment, and CNS therapies. But the complexity and stringent security measures required to handle controlled substances mean that working with the right CDMO partner is vital.
Originating from Macfarlan Smith Ltd, a globally recognized leader in opiate alkaloids, Veranova has unparalleled knowledge of controlled substance development and manufacturing. Leveraging robust infrastructure for handling, security, waste management, and audit readiness, our dedicated procedures and training help to ensure that APIs are developed and stored safely.
Our highly skilled professionals support our portfolio growth and help expedite product entry to market. Through close, collaborative partnerships, Veranova supports alignment between clients and regulatory agencies.
Learn more about our approach to quality and regulatory affairs
Our world-class US and UK facilities are GMP compliant. Each site holds the proper licenses to handle controlled substances.
From clinical to commercial scale, we combine consistent supply with flexible capacity to help ensure we meet our customers’ needs at every stage of the drug approval process
Discover new ways to advance your science with Veranova.
Contact us